

This Pneumonia study looked at how chest X-ray data affect antibiotic starting by general practitioners in France when treating patients with probable pneumonia.
Method of study
A prospective cross-sectional investigation was carried out on adult patients with probable pneumonia who underwent chest X-rays as part of their examination. To investigate factors related with antibiotic initiation, patients’ characteristics were compared at inclusion and at 28 days between those with positive chest X-rays (indicating pneumonia) and those with negative chest X-rays.
Main results
The sample comprised 259 adult patients. The median age was 58 years; 120 (46.3%) were men; 249 (96.1%) had not received antibiotics previous to inclusion; and 69 (26.7%) had at least one risk factor for pneumococcal illness.
- The majority of the general practitioners who treated patients were women (55.2%; n = 153), with a median age of 39 years. 76.1% (n = 210) were general practitioner trainers.
- 55.6% of patients (144 out of 259) obtained positive chest X-rays.
- Patients with positive chest X-ray results had greater body temperature, quicker heart rate, faster breathing rate, more trouble breathing, and more frequent unilateral chest discomfort than patients with negative X-ray results, and their symptoms persisted for longer periods of time.
- Antibiotics were prescribed to 99.3% of patients who had positive chest X-ray results. Despite having less symptoms and negative chest X-ray results, 79 out of 115 patients (68.75%) were prescribed antibiotics.
Why does it matter?
This study found that many general practitioners administer antibiotics for suspected community-acquired pneumonia even when chest X-ray results are negative, revealing a gap between guidelines and actual practice.
more recommended stories
Key Immune Pathways in Centenarians Identified
Centenarians Offer Clues to Healthy Aging.
Action Video Games and Brain Health: Study Insights
Gaming and Brain Structure: What MRI.
Creatine May Boost Muscle Strength in Alzheimer’s Patients
Creatine Supplementation Shows Promise in Alzheimer’s.
New Drug STF-1623 Shows Promise in Treating Solid Tumors
STF-1623 Transforming ‘Cold’ Tumors into ‘Hot’.
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
CDI Test Shows Early Detection Potential in Alzheimer’s
Breakthrough Study Highlights Brain Blood Flow.
Prenatal Chlorpyrifos Exposure and Pediatric Brain Changes
A Growing Concern in Pediatric Neurodevelopment.
Valve Deterioration After TAVI: New Research Insights
The Growing Role of TAVI in.
Leave a Comment